American Century Buy or Sell Recommendation

    Macroaxis provides American Century Mid Cap Value R6 buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding American Century positions. The advice algorithm takes into account all of American Century Mid Cap Value R6 available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from American Century buy-and-hold prospective. Check also Trending Equities.

    Time Horizon

    Risk Tolerance

    Symbol
    Execute Advice
    American Century Mid Cap Value R6 -- USA Fund  

    USD 17.07  0.00  0.00%

    Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding American Century Mid Cap Value R6 is 'Not Rated'.
    For the selected time horizon American Century Mid Cap Value R6 has a risk adjusted performance of 0.36, jensen alpha of 0.25, total risk alpha of 0.14, sortino ratio of 0.0 and treynor ratio of 1.55
    This buy or sell advice tool can be used to cross verify current analyst consensus on American Century Mid and to analyze the fund potential to grow in the current economic cycle. Use American Century Mid Price to Book, Five Year Return as well as the relationship between Five Year Return and Bond Positions Weight to make sure your buy or sell decision on American Century Mid is adequate.

    Returns Distribution Density

    Mean Return0.22Value At Risk1.93
    Potential Upside0.84Standard Deviation1.04
     Return Density 
          Distribution 
    SellBuy
    Not Rated
    Alpha Finder
    Use alpha and beta coefficients to find investment opportunities after accounting for the risk
    Find Alpha
    Equity Screener
    Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
    Research Equities
    Insiders Screener
    Find insiders across different sectors to evaluate their impact on performance and growth of their entities
    Research Insiders